S t u d y s e l e c t i o n
Studies were selected if they were randomized controlled trials (RCTs) or controlled clinical trials (CCTs) of exercise interventions lasting ≥ 8 weeks in patients with type 2 diabetes in whom compliance could be verified by direct supervision or diaries.
D a t a e x t r a c t i o n
2 investigators independently extracted data on sample size, baseline and post-treatment means and standard deviations of the intervention and control groups for HbA 1c levels and body mass, exercise-program characteristics (type, frequency, duration, intensity, and energy cost), and study quality (randomization, blinding, withdrawals, and concealment).
M a i n r e s u l t s 14 trials (11 RCTs) were included (504 patients, mean age 55 y, 50% men, mean duration of diabetes 4.6 y). The duration of the intervention ranged from 8 to 52 weeks (mean 18 wk). Study quality was moderate to low (mean score 1.6 out of 5 points). 12 trials that compared exercise with no exercise showed reduced HbA 1c levels with the exercise program (P < 0.001) ( Table) . 2 trials that compared diet plus exercise with no diet and no exercise also showed reduced HbA 1c levels with the intervention (P = 0.008) (Table) . A sensitivity analysis showed no difference between results from RCTs and CCTs (Table) . The results did not differ by type of exercise (aerobic vs resistance training). Exercise alone (12 trials, P = 0.60) or combined with diet (2 trials, P = 0.24) did not reduce body mass (Table) . The results did not differ when RCTs, CCTs, aerobic training, or resistance training were analyzed separately. Meta-regression analysis showed that the reduction in HbA 1c levels could not be predicted by change in body mass, exercise intensity, or total amount of exercise.
C o n c l u s i o n
In patients with type 2 diabetes mellitus, exercise training reduces HbA 1c levels but does not reduce body mass. 
C o m m e n t a r y
Exercise is widely recommended to patients with type 2 diabetes mellitus. Evidence for its effect on glycemic control, however, is scarce. Although patients enrolled in exercise programs obviously increase their energy output, they may compensate by spending less energy in other daily activities-a decrease in energy expenditure that is rarely accounted for in most studies (1, 2) . Without adjustment for overall energy expenditure and other factors associated with exercise, it is difficult to predict the independent effect of exercise interventions on body mass and glycemia, which also makes it difficult to provide specific recommendations to patients and practiance. The meta-analysis by Boulé and colleagues shows that three 45-minute moderate-intensity aerobic workouts per week (similar to the activity goals specified in the clinical guidelines for the treatment of obesity [3]) can reduce HbA 1c levels to a degree sufficient to reduce risk for myocardial infarction by 9% and microvascular complications by 24%, according to U.K. Prospective Diabetes Study Group data (4 Exercise + diet vs no exercise and no diet 3 0.20 (−0.54 to 0.14)
*HbA 1c = glycosylated hemoglobin; RCTs = randomized controlled trials.
